1. Samtani, Ratika, Bajpai, Minu, Ghosh, P K, Saraswathy, K N. . SRD5A2 gene mutations--a population-based review. In Pediatric endocrinology reviews : PER, 8, 34-40. doi:. https://pubmed.ncbi.nlm.nih.gov/21037542/
2. Francis, Amirtharaj, Sarkar, Saumya, Pooja, Singh, Thangaraj, Kumarasamy, Rajender, Singh. 2013. SRD5A2 gene polymorphisms affect the risk of breast cancer. In Breast (Edinburgh, Scotland), 23, 137-41. doi:10.1016/j.breast.2013.11.010. https://pubmed.ncbi.nlm.nih.gov/24365257/
3. Duan, Honglei, Wang, Xu, Qi, Wenqian, Liu, Jia, Wang, Jiangbin. 2023. Two genetic variants in the SRD5A2 gene are found to be associated with sex differences in the disease characteristics of patients with chronic hepatitis B virus infection. In Biology of sex differences, 14, 68. doi:10.1186/s13293-023-00553-4. https://pubmed.ncbi.nlm.nih.gov/37784175/
4. Li, Jun, Coates, Ralph J, Gwinn, Marta, Khoury, Muin J. 2009. Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review. In American journal of epidemiology, 171, 1-13. doi:10.1093/aje/kwp318. https://pubmed.ncbi.nlm.nih.gov/19914946/
5. Choubey, Vimal Kumar, Sankhwar, Satya Narayan, Carlus, S Justin, Thangaraj, Kumarasamy, Rajender, Singh. . SRD5A2 gene polymorphisms and the risk of benign prostatic hyperplasia but not prostate cancer. In Asian Pacific journal of cancer prevention : APJCP, 16, 1033-6. doi:. https://pubmed.ncbi.nlm.nih.gov/25735326/
6. Aggarwal, Suruchi, Singh, Minu, Kumar, Ashok, Mukhopadhyay, Tapas. 2015. SRD5A2 gene expression inhibits cell migration and invasion in prostate cancer cell line via F-actin reorganization. In Molecular and cellular biochemistry, 408, 15-23. doi:10.1007/s11010-015-2478-z. https://pubmed.ncbi.nlm.nih.gov/26092425/
智鼠故事 
